Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
53,136,600
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
27,785,299
-
Shares change
-
-1,286,146
-
Total reported value, excl. options
-
$51,273,440
-
Value change
-
+$2,395,861
-
Put/Call ratio
-
0%
-
Number of buys
-
16
-
Number of sells
-
38
-
Price
-
$1.83
Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2025
As of 30 Sep 2025 ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,785,299 shares of stock of the company.
Largest 10 holders included venBio Partners LLC, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, Almitas Capital LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Driehaus Capital Management LLC, TWO SIGMA ADVISERS, LP, AMERIPRISE FINANCIAL INC, and TWO SIGMA INVESTMENTS, LP.
This table shows 72 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.